Invenomic Capital Management’s Dole DOLE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$19.6M Sell
1,430,966
-329,343
-19% -$4.79M 1.17% 30
2026
Q1
$25.2M Buy
1,760,309
+162,858
+10% +$2.47M 1.15% 30
2025
Q4
$23.9M Buy
1,597,451
+56,492
+4% +$787K 1.11% 25
2025
Q3
$20.7M Buy
1,540,959
+301,319
+24% +$4.23M 1% 32
2025
Q2
$17.3M Buy
1,239,640
+243,785
+24% +$3.45M 0.98% 34
2025
Q1
$14.4M Buy
995,855
+840,014
+539% +$11.6M 0.73% 47
2024
Q4
$2.11M Buy
+155,841
New +$2.39M 0.1% 146
2022
Q2
Sell
-395,476
Closed -$3.92M 158
2022
Q1
$3.92M Buy
395,476
+120,775
+44% +$1.67M 0.42% 72
2021
Q4
$3.66M Buy
+274,701
New +$3.84M 0.78% 47

Other funds holding DOLE

Invenomic Capital Management's DOLE Position: Q2 2026 in Review

Invenomic Capital Management reduced its Dole (DOLE) stake by 19% in Q2 2026, selling an estimated $4.79M and leaving 1,430,966 shares worth $19.6M. The position accounts for 1.17% of the portfolio, ranked #30.

Invenomic Capital Management first reported a position in DOLE in Q4 2021 and has held it in 9 quarters since. The position peaked at $25.2M in Q1 2026. 212 funds tracked by Wall St. Rank hold DOLE as of Q2 2026.

  • Invenomic Capital Management held 1,430,966 shares of Dole worth $19.6M as of Q2 2026.
  • Invenomic Capital Management sold 329,343 Dole shares in Q2 2026, an estimated $4.79M.
  • Dole made up 1.17% of Invenomic Capital Management's portfolio in Q2 2026, its #30 holding.
  • Invenomic Capital Management first reported a position in Dole in Q4 2021 and has held it in 9 quarters since.
  • Invenomic Capital Management's Dole position peaked at $25.2M in Q1 2026.
  • 212 funds tracked by Wall St. Rank held Dole as of Q2 2026.

Based on Invenomic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.